PMP22 and Charcot-Marie-Tooth disease type 1A: Although we identified 1 differential metabolite (acetylcarnitine) in CMT1A cohort, in the predictive model of CMT1A all metabolites showed poor accuracy for predicting the disease (AUC < 0.73) (Figure 3).